Stock screener

MLTX

Conviction 65HealthcareScan · Thu, Jun 25, 2026
MLTX$20.01+0.05%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.44M
Mar 26Apr 14May 1May 19Jun 8Jun 25
MoonLake ImmunotherapeuticsPHARMACEUTICAL PREPARATIONSwww.moonlaketx.com ↗
Price20.01
Change+0.05%
Gap+1.25%
Rel volume1.25×
Avg volume1.23M
Avg $ vol24.18M
SMA 2018.96
SMA 5018.07
SMA 20018.04
Price vs 50+10.73%
Price vs 200+10.95%
MA stackbullish
50/200 crossgolden · 0d
Supertrendup · 17.70
RSI (14)57
MACD hist0.19
MACD crossbull · 7d
Stoch %K / %D48 / 54
ADX (14)29
+DI / −DI32 / 18
RSI divergence—
MACD divergence—
ATR %+6.29%
ADR %5.65%
52w high61.99
52w low6.25
From 52w high-67.72%
Above 52w low+220.42%
New 52w highNo
SqueezeOff
Bollinger width24.36%
%B0.73
Donchian pos47.85%
Donchian high23.29
Donchian low17.00
AVWAP (52w high)12.01
vs AVWAP high+66.61%
AVWAP (52w low)11.90
vs AVWAP low+68.11%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d1.25×
Avg vol (14d)1.44M
Avg vol (20d)1.23M
Avg $ vol (20d)24.18M
Market cap1.47B
RS 3m (vs SPY)+7.43%
RS 6m (vs SPY)+41.63%
RS line new highNo
Trend template4/8
Technical rank79.3
1 week+4.27%
1 month+9.76%
3 months+11.04%
6 months+48.33%
1 year-56.27%
YTD+67.45%
P/E-6.48
P/B5.80
P/S—
P/FCF-7.51
EPS-3.53
Div yield—
ROE-89.49%
ROA-56.78%
Debt/Eq0.39
Current8.60
EV/EBITDA-5.26
Gross margin—
Net margin—
Rev growth—
EPS growth-91.13%
Price target34.44
Target upside72.11%
Analyst ratingBuy
Institutional86.61%
Ent. value1.27B
Revenue—
Net income-69.71M
Gross profit—
Free cash flow-196.04M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out73.62M
Employees130
ListedWed, Apr 6, 2022
Free float43.93M
Float %61.3%
Short interest5.57M
Days to cover6.9d
Short volume9.5%
Squeeze score54 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.91 · 4 est
Last EPS vs est−$0.98 vs −$0.91
Last surprise-7.7% miss
Setup gradeB
Conviction65 / 100
Pattern quality—
Tech rank79.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance22.15
Support16.32
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MLTX

All disclosures →
No recent disclosed trades by Congress in MLTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MLTX · 5 buys · 5 sells

InsiderSideShares
BVF PARTNERS L P/IL
Director · Option to Buy · 2026-06-17
Grant22.2K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-18
Sell2.79K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-06-17
Sell15.08K
Loy Spike
Director · Option to Buy · 2026-06-17
Grant22.2K
Moukheibir Catherine
Director · Option to Buy · 2026-06-17
Grant22.2K
Phillips Andrew John
Director · Option to Buy · 2026-06-17
Grant22.2K
Xavier Ramnik
Director · Option to Buy · 2026-06-17
Grant22.2K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-05-11
Sell13.65K
Bodenstedt Matthias
Chief Financial Officer · Class A ordinary shares, par value $0.0001 per share · 2026-04-14
Sell2.43K
Santos da Silva Jorge
Chief Executive Officer · Class A ordinary shares, par value $0.0001 per share · 2026-04-13
Sell51.87K

SEC filings

EDGAR filings in MLTX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.